Document Detail

Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation.
MedLine Citation:
PMID:  22178057     Owner:  NLM     Status:  Publisher    
BACKGROUND: Atrial remodeling is considered as the structural basis for the development and sustaining of atrial fibrillation (AF). Osteoprotegerin (OPG)/receptor activator of nuclear factor-κB (RANK)/RANK ligand (RANKL) axis, a key regulatory system in bone metabolism, was recently identified in some cardiovascular disorders for its regulation to myocardial remodeling. We hypothesized that the OPG/RANK/RANKL axis is involved in development and perpetuation of AF by regulating atrial remodeling. METHODS: Biopsies of right atrial appendage and clinical data were collected from sex- and age-matched 24 persistent AF, 24 paroxysmal AF, 24 sinus rhythm (SR) patients undergoing isolated mitral valve surgery and 24 healthy heart donors (normal controls). RESULTS: A significantly increasing gradient of atrial expression of OPG, RANKL, RANK and RANKL/OPG ratio was identified in normal controls, SR and AF groups. RANKL/OPG ratio was also found significantly higher in paroxysmal AF than persistent AF. Furthermore, atrial expression and activity of the axis was statistically correlated with collagen III/I levels and ratio and the degree of interstitial fibrosis reflected by collagen volume fraction in right atrial appendages. CONCLUSIONS: The present findings suggest a potential role for known mediators of bone homeostasis in the pathogenesis of AF and possibly represent new targets for therapeutic intervention in AF.
Hailong Cao; Qingguo Li; Mingna Li; Røe Od; Zhong Wu; Qing Zhou; Bin Cao; Baojun Chen; Yijiang Chen; Dongjin Wang
Related Documents :
19484157 - Isolated left ventricular noncompaction diagnosed by transthoracic threedimensional ech...
22368507 - Fbg sensor for contact level monitoring and prediction of perforation in cardiac ablation.
6404787 - The mechanics of ventricular function.
21659487 - Silencing of nhe-1 blunts the slow force response to myocardial stretch.
2671277 - Aids-related heart disease: a review of the literature.
8844437 - Nicorandil: a potassium channel opening drug for treatment of ischemic heart disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-15
Journal Detail:
Title:  International journal of cardiology     Volume:  -     ISSN:  1874-1754     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Department of Thoracic and Cardiovascular Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acute heart failure in patients with diabetes mellitus: Clinical characteristics and predictors of i...
Next Document:  MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humans.